Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Marts 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.5k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktørH Offline
    Helge_LarsenPI-redaktør
    wrote on sidst redigeret af
    #218

    God morgen. 🙂

    1 Reply Last reply
    0
    • B Offline
      B Offline
      bibob
      wrote on sidst redigeret af
      #219

      God morgen. 🙂

      1 Reply Last reply
      0
      • B Offline
        B Offline
        bibob
        wrote on sidst redigeret af
        #220

        Upfront multidrug regimens prove beneficial in Myeloma. https://www.onclive.com/web-exclusives/upfront-multidrug-regimens-prove-beneficial-in-myeloma

        1 Reply Last reply
        0
        • B Offline
          B Offline
          bibob
          wrote on sidst redigeret af
          #221

          Just a moment...

          favicon

          (www.onclive.com)

          1 Reply Last reply
          0
          • B Offline
            B Offline
            bibob
            wrote on sidst redigeret af
            #222

            Dr. Raje on the efficacy of Belantamab Mafodotin in Multiple Myeloma. https://www.onclive.com/onclive-tv/dr-raje-on-the-efficacy-of-belantamab-mafodotin-in-multiple-myeloma

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #223

              De håber at kunne løse problemet med øjnene. Virker ikke som om hun er særlig begejstret før det er løst.

              1 Reply Last reply
              0
              • S Offline
                S Offline
                Sukkeralf
                wrote on sidst redigeret af
                #224

                Sutro har et BCMA ADC under udvikling i samarbejde med BMS (tidligere Celgene), hvor man forventer at bivirkningsprofilen vil være markant bedre end GSKs BCMA ADC, da man anvender site specific conjugation. Sutro´s to egne ADC´er i klinikken har indtil videre ikke vist occular toxicity. Forventningen er at stoffet skal kunne gives på community centers ! Blot en lille reklame for Sutro 🙂

                1 Reply Last reply
                0
                • StockBullS Offline
                  StockBullS Offline
                  StockBull
                  wrote on sidst redigeret af
                  #225

                  nemlig 1584

                  1 Reply Last reply
                  0
                  • A Offline
                    A Offline
                    AaBforever
                    wrote on sidst redigeret af
                    #226

                    Nu 1558..:-(

                    1 Reply Last reply
                    0
                    • A Offline
                      A Offline
                      AaBforever
                      wrote on sidst redigeret af
                      #227

                      Det er svært at være daytrader i disse tider...nogle dage skal man starte ud med bull andre dage bear. Men hvis man rammer er der penge i Genmab.

                      1 Reply Last reply
                      0
                      • T Offline
                        T Offline
                        Thetreble
                        wrote on sidst redigeret af
                        #228

                        Sarclisa fra Sanofi bliver billigere end Genmab - er dette middel en trussel mod dara salget ?

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          GeorgeBest
                          wrote on sidst redigeret af
                          #229

                          Ja i tredie linie er det. Vincent Rajkumar har på Twitter meddelt at han vil bruge Sarclisa i Pom/Dex kombien hvis det er billigere...

                          1 Reply Last reply
                          0
                          • G Offline
                            G Offline
                            GeorgeBest
                            wrote on sidst redigeret af
                            #230

                            Sarclisa er kun godkendt til tredie linie plus patienter, så i første og anden linie er det ikke en trussel, og det er langt det største marked

                            1 Reply Last reply
                            0
                            • G Offline
                              G Offline
                              GeorgeBest
                              wrote on sidst redigeret af
                              #231

                              Nogen der ved hvornår Sarclisa kan blive godkendt i 1. og 2. linie?

                              1 Reply Last reply
                              0
                              • BulderB Offline
                                BulderB Offline
                                Bulder
                                wrote on sidst redigeret af
                                #232
                                1. linje dette her fase 3 - Ikema: https://www.clinicaltrials.gov/ct2/show/NCT03275285?term=isatuximab+mm&draw=2&rank=4
                                1 Reply Last reply
                                0
                                • BulderB Offline
                                  BulderB Offline
                                  Bulder
                                  wrote on sidst redigeret af
                                  #233

                                  Det eneste 1. linje jeg har kunnet finde er dette fase 1: https://www.clinicaltrials.gov/ct2/show/NCT02513186?term=isatuximab+mm&draw=2&rank=2

                                  1 Reply Last reply
                                  0
                                  • BulderB Offline
                                    BulderB Offline
                                    Bulder
                                    wrote on sidst redigeret af
                                    #234

                                    Så Ikema i 2. linje bliver det næste med primary completion til november og tidligst godkendelse sidst i 2021.

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      GeorgeBest
                                      wrote on sidst redigeret af
                                      #235

                                      Tak Bulder

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #236

                                        this NKTCL trial was recently completed; should we expect a Ph III trial to be started? https://clinicaltrials.gov/ct2/show/NCT02927925?term=NKTCL+AND+daratumumab&draw=2&rank=1

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          GeorgeBest
                                          wrote on sidst redigeret af
                                          #237

                                          There were some years ago stories about fantastic outcome for some patients with NKTCL who received dara. But since then it has been quite.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger